Pulmonx Corp
Pulmonx Corp (LUNG) Options Open Interest
LUNG options open interest is 2,875 contracts. The 2-week average daily volume is 214 contracts across the chain.
Read more
Monitoring LUNG open interest helps you see where real money is positioned on Pulmonx Corp's options and which strikes are attracting the most commitment from traders. Pulmonx Corp's open interest reflects the total number of outstanding contracts that have not been closed or exercised, making it a powerful gauge of liquidity, conviction, and potential support and resistance zones. Use our scanner to monitor LUNG options open interest in real time and find the strikes that matter.
Open interest is distinct from volume: volume counts how many contracts are traded in a session, while open interest counts how many remain open at the end of the day. Rising LUNG options open interest alongside rising volume suggests new positions are being built, while falling open interest signals positions are being closed. Heavy open interest at specific strikes often acts as a magnet near expiration and can hint at where dealers and large traders expect Pulmonx Corp to settle.
Pulmonx Corporation, a medical technology company, provides minimally invasive devices for the treatment of chronic obstructive pulmonary diseases. It offers Zephyr Endobronchial Valve, a solution for the treatment of bronchoscopic in adult patients with hyperinflation associated with severe emphysema; and Chartis Pulmonary Assessment System, a balloon catheter and console system with flow and pressure sensors that are used to assess the presence of collateral ventilation. The company also provides StratX Lung Analysis Platform, a cloud-based quantitative computed tomography analysis service that offers information on emphysema destruction, fissure completeness, and lobar volume to help identify target lobes for the treatment with Zephyr Valves.
It serves emphysema patients in the United States, Europe, the Middle East, Africa, the Asia-Pacific, and internationally. The company was formerly known as Pulmonx and changed its name to Pulmonx Corporation in December 2013. Pulmonx Corporation was incorporated in 1995 and is headquartered in Redwood City, California.
Pin risk into expiration, dealer positioning, liquidity checks for large orders — all of it starts with knowing where LUNG open interest is concentrated. Our scanner maps Pulmonx Corp's open interest across every strike and expiry, flags unusual buildups, and lets you drill into the contracts that institutional money is actually holding. Trade Pulmonx Corp's options open interest as the signal it is, not as an afterthought.
| 2.50 | — | 0.10 | 0.10 | 105% | +0.3056 | 1,756 |
| 5.00 | — | 0.05 | 0.05 | 211% | +0.1085 | 0 |
| 7.50 | — | 0.75 | 0.75 | 642% | +0.5567 | 0 |
| 2.50 | 0.20 | 0.95 | 0.58 | 130% | -0.6354 | 0 |
| 5.00 | 2.40 | 3.40 | 2.90 | 27% | -1.0000 | 0 |
| 7.50 | 5.00 | 6.00 | 5.50 | 313% | -0.8584 | 0 |
As of September 18, 2026
Follow the money
Track LUNG open interest across every strike and expiration, identify where conviction is building, and trade with the positioning data on your side.
Start your 14-day free trial→